Vertex Pharmaceuticals Inc Capital Reinvestment Ratio
Vertex Pharmaceuticals Inc capital reinvestment ratio. Vertex Pharmaceuticals Inc (VRTX) has a Capital Reinvestment Ratio of 0.10x as of June 2026, meaning it reinvests 0% of its operating cash flow ($1.13 Billion) in capital expenditures ($112.20 Million). See Vertex Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Vertex Pharmaceuticals Inc (1993–2025)
Capital reinvestment ratio of Vertex Pharmaceuticals Inc from 1993 to 2025. This chart tracks Vertex Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods. See VRTX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Vertex Pharmaceuticals Inc Capital Reinvestment Ratio by Year (1993–2025)
Vertex Pharmaceuticals Inc capital reinvestment ratio by year from 1993 to 2025. For the full cash flow conversion analysis, see how efficiently does Vertex Pharmaceuticals Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $3.63 Billion | $437.60 Million | ▲ +65.0% |
| 2023 | 0.07x | $3.54 Billion | $258.40 Million | ▲ +47.4% |
| 2022 | 0.05x | $4.13 Billion | $204.70 Million | ▼ -44.2% |
| 2021 | 0.09x | $2.64 Billion | $235.00 Million | ▲ +11.3% |
| 2020 | 0.08x | $3.25 Billion | $259.80 Million | ▲ +66.1% |
| 2019 | 0.05x | $1.57 Billion | $75.45 Million | ▼ -36.1% |
| 2018 | 0.08x | $1.27 Billion | $95.52 Million | ▼ -75.5% |
| 2017 | 0.31x | $844.94 Million | $259.42 Million | ▲ +28.2% |
| 2016 | 0.24x | $236.10 Million | $56.56 Million | ▼ -9.8% |
| 2012 | 0.27x | $267.84 Million | $71.14 Million | ▼ -59.6% |
| 2011 | 0.66x | $143.74 Million | $94.59 Million | ▲ +214.4% |
| 1993 | 0.21x | $8.60 Million | $1.80 Million | — |